IS8399A - Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns - Google Patents
Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólínsInfo
- Publication number
- IS8399A IS8399A IS8399A IS8399A IS8399A IS 8399 A IS8399 A IS 8399A IS 8399 A IS8399 A IS 8399A IS 8399 A IS8399 A IS 8399A IS 8399 A IS8399 A IS 8399A
- Authority
- IS
- Iceland
- Prior art keywords
- phenylsulfonyl
- polyphenyl
- piperazin
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (en) | 2003-09-26 | 2004-09-23 | A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8399A true IS8399A (is) | 2006-04-05 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8399A IS8399A (is) | 2003-09-26 | 2006-04-05 | Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (is) |
| EP (1) | EP1667975B1 (is) |
| JP (1) | JP2007506702A (is) |
| CN (1) | CN1856471A (is) |
| AU (1) | AU2004283805A1 (is) |
| BR (1) | BRPI0414678A (is) |
| CA (1) | CA2540022A1 (is) |
| CO (1) | CO5680402A2 (is) |
| DE (1) | DE602004010410T2 (is) |
| DK (1) | DK1667975T3 (is) |
| ES (1) | ES2297465T3 (is) |
| GB (1) | GB0322629D0 (is) |
| HK (1) | HK1094190A1 (is) |
| HR (1) | HRP20080055T3 (is) |
| IL (1) | IL174213A0 (is) |
| IS (1) | IS8399A (is) |
| MA (1) | MA28093A1 (is) |
| MX (1) | MXPA06003375A (is) |
| NO (1) | NO20061791L (is) |
| PL (1) | PL1667975T3 (is) |
| PT (1) | PT1667975E (is) |
| RU (1) | RU2355681C2 (is) |
| WO (1) | WO2005040124A1 (is) |
| ZA (1) | ZA200601453B (is) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60321558D1 (de) * | 2002-03-27 | 2008-07-24 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
| TW200523253A (en) | 2003-07-22 | 2005-07-16 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| NZ542865A (en) | 2003-09-18 | 2009-04-30 | Virobay Inc | Haloalkyl containing compounds as cysteine protease inhibitors |
| CA2610456A1 (en) | 2005-06-02 | 2006-12-07 | F. Hoffmann-La Roche Ag | 3-methanesulfonylquinolines as gaba-b enhancers |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| WO2008113818A1 (en) * | 2007-03-21 | 2008-09-25 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
| US9084742B2 (en) | 2007-12-12 | 2015-07-21 | Axovant Sciences Ltd. | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
| RU2018103338A (ru) | 2015-07-15 | 2019-08-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием |
| WO2017202206A1 (zh) * | 2016-05-27 | 2017-11-30 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的喹啉化合物及其药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| DE60321558D1 (de) * | 2002-03-27 | 2008-07-24 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
-
2004
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/en active IP Right Grant
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
- 2004-09-23 EP EP04765655A patent/EP1667975B1/en active Active
- 2004-09-23 CA CA002540022A patent/CA2540022A1/en not_active Abandoned
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es active Active
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
- 2006-11-29 HK HK06113097A patent/HK1094190A1/xx not_active IP Right Cessation
-
2008
- 2008-02-04 HR HR20080055T patent/HRP20080055T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5680402A2 (es) | 2006-09-29 |
| DE602004010410D1 (en) | 2008-01-10 |
| IL174213A0 (en) | 2006-08-01 |
| PT1667975E (pt) | 2008-02-29 |
| MXPA06003375A (es) | 2006-06-08 |
| MA28093A1 (fr) | 2006-08-01 |
| HRP20080055T3 (en) | 2008-02-29 |
| CA2540022A1 (en) | 2005-05-06 |
| BRPI0414678A (pt) | 2006-11-28 |
| GB0322629D0 (en) | 2003-10-29 |
| RU2006114024A (ru) | 2007-11-10 |
| WO2005040124A1 (en) | 2005-05-06 |
| DE602004010410T2 (de) | 2008-10-16 |
| CN1856471A (zh) | 2006-11-01 |
| EP1667975B1 (en) | 2007-11-28 |
| HK1094190A1 (en) | 2007-03-23 |
| ES2297465T3 (es) | 2008-05-01 |
| DK1667975T3 (da) | 2008-04-14 |
| EP1667975A1 (en) | 2006-06-14 |
| AU2004283805A1 (en) | 2005-05-06 |
| ZA200601453B (en) | 2007-04-25 |
| JP2007506702A (ja) | 2007-03-22 |
| NO20061791L (no) | 2006-04-24 |
| PL1667975T3 (pl) | 2008-04-30 |
| RU2355681C2 (ru) | 2009-05-20 |
| US20070032504A1 (en) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8399A (is) | Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns | |
| DE602004018654D1 (de) | Se | |
| ATE363383T1 (de) | Schlingenware | |
| DE602004018837D1 (de) | Ptidase-iv-inhibitoren | |
| AT502792A5 (de) | Düsenanpressvorrichtung | |
| FI20030261A (fi) | Iskulaite | |
| JP2006502186A5 (ja) | β-グルカンの使用 | |
| DE112004000620D2 (de) | Struktoguss | |
| DE502004000672D1 (de) | Pigmentpreparationen | |
| DE502004001524D1 (de) | Hydrolager | |
| ATA662003A (de) | Trink-mundstück | |
| ITPS20030026A1 (it) | Struttura di osteotomo. | |
| DE502004005544D1 (de) | Mikrodosiereinrichtung | |
| ATE446959T1 (de) | Chromenonindole | |
| DE502004000518D1 (de) | Mitgängergabelhubwagen | |
| DE10394329D2 (de) | Mäanderstent | |
| DE10355350A8 (de) | Elektromodul | |
| FR2877833B1 (fr) | Correcteur de lordoses | |
| ATE406350T1 (de) | Prolinylarylacetamide | |
| DE112004002227D2 (de) | Nietverarbeitungsgerät | |
| DE10329218B4 (de) | Hotflue | |
| DE112004001561D2 (de) | Getriebene-Antreibseinheit | |
| DE20317661U1 (de) | Faltkleiderschrank | |
| FR2851121B1 (fr) | Dechaumeuse de precision | |
| DE502004001283D1 (de) | Umsymmetrieranordnung |